VM 26 in advanced mycosis fungoides

U. Tirelli, A. Carbone, S. Tumolo, E. Galligioni, A. Veronesi, M. G. Trovò, E. Grigoletto

Research output: Contribution to journalArticlepeer-review

Abstract

Five consecutive patients with progressive extracutaneous stage IV mycosis fungoides (MF) were treated with VM 26, 100 mg/m2 i.v., for at least 3 cycles. All patients had been extensively pretreated and in particular with vinca alkaloids. Two partial responses of 5 and 9+ months duration and 1 minimal response of 5 months duration were obtained. Transient myelosuppression was encountered in all patients. These preliminary results should encourage further exploration of VM 26, even in less advanced MF.

Original languageEnglish
Pages (from-to)487-490
Number of pages4
JournalTumori
Volume67
Issue number5
Publication statusPublished - 1981

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'VM 26 in advanced mycosis fungoides'. Together they form a unique fingerprint.

Cite this